• Richard A Dart MD, MACP, FCCP, FAHA, FASN, FA

  • Emeritus Research Clinician


    • Center for Precision Medicine Research
    • 1000 North Oak Ave. MLR Marshfield, WI 54449

Education


1971 to 1973:
Hypertension/Nephrology, Cleveland Clinic, Cleveland
1968 to 1971:
Internal Medicine, Cleveland Clinic, Cleveland
1965 to 1966:
Internal Medicine, Cook County, Chicago
1961 to 1965:
MD, University of Illinois, College of Medicine, Chicago
1959 to 1961:
BS, Zoology, University of Illinois, Urbana
1957 to 1959:
Long Beach City College, Long Beach

Work Experience


2007 to Present:
Emeritus Researcher - Center for Human Genetics, Marshfield Clinic Research Foundation, Marshfield
2010 to 2015:
Re-appointment Clinical Professor of Medicine, Collateral Faculty, UW-Madison, Madison
2005 to 2010:
Re-appointment Clinical Professor of Medicine, Collateral Faculty - UW-Madison, Madison
1993 to 2007:
Vice Chair - Department of Nephrology, Marshfield Clinic, Marshfield
1975 to 2007:
Staff Physician, Ministry St. Joseph's Hospital, Marshfield
1975 to 2007:
Staff, Ministry St. Joseph's Hospital, Marshfield
1973 to 2007:
Director and Staff Physician, Marshfield Clinic, Marshfield
1973 to 2007:
Department of Nephrology/Hypertension, Marshfield Clinic, Marshfield
1973 to 2007:
Member - Department of Nephrology/Hypertension, Marshfield Clinic, Marshfield
2000 to 2005:
Re-appointment Clinical Professor of Medicine, Collateral Faculty - UW-Madison, Madison
1995 to 2000:
Clinical Professor of Medicine, Collateral Faculty - UW-Madison - Marshfield Campus, Madison
1991 to 1993:
Department Chair, Marshfield Clinic, Marshfield
1980 to 1991:
Section Chief, Marshfield Clinic, Marshfield
1984 to 1985:
Clinical Associate Professor of Medicine, Collateral Faculty - UW-Madison -Marshfield Campus, Madison
1982 to 1984:
Clinical Assistant Professor of Medicine, UW-Madison - Marshfield Campus, Marshfield
1978 to 1980:
Secretary Medical Staff, Ministry St. Joseph's Hospital, Marshfield
1973 to 1975:
Associate Member, Marshfield Clinic, Marshfield
1973 to 1975:
Associate Staff Physician, Ministry St. Joseph's Hospital, Marshfield
1966 to 1968:
Flight Surgeon, United States Air Force, Lockbourne AFB

Board Certifications


1978 to Present:
Internal Medicine
1978 to Present:
Nephrology

Honors & Awards


1973:
Peskind Fellowship Award - Cleveland Clinic, Cleveland OH
1989:
Physician Volunteer of the Year - State of Wisconsin - American Heart Association
1994:
Addis Costello Internist of the Year Award - Wisconsin Society of Internal Medicine
1999:
American Society of Hypertension Specialist in Clinical Hypertension
2003:
Laureate Award - Wisconsin Chapter - American College of Physicians

Research Interests


Hypertension and Renal Diseases
Bioethics

Professional Societies


1974 to 1976:
Member - Infectious Disease Control Committee
1975 to 1976:
Member until combined with ACP - Wisconsin Society of Internal Medicine Wisconsin Affiliate
1975 to 1977:
Chair - Patient Services Committee - National Kidney Foundation of Wisconsin
1974 to 1978:
Member - Combined Medical Education Committee - Marshfield Clinic, Marshfield, Wisconsin
1977 to 1978:
Chair - Board of Directors - North Central Chapter - National Kidney Foundation of Wisconsin Affiliate
1974 to 1979:
Member - Medical Audit Committee - Marshfield Clinic, Marshfield, Wisconsin
1975 to 1979:
Member - Medical Record and Utilization and Review Committee
1976 to 1979:
Member - Patient Advisory Committee - Marshfield Clinic, Marshfield, Wisconsin
1977 to 1979:
Chairman - Resident Applicant Selection Committee - Marshfield Clinic, Marshfield, Wisconsin
1977 to 1979:
Member - Research Committee - Marshfield Clinic Research Foundation
1978 to 1980:
Chair - Medical and Scientific Committee - National Kidney Foundation of Wisconsin Affiliate
1980 to 1980:
Vice President - Executive Committee - North Central Chapter - National Kidney Foundation of Wisconsin Affiliate
1977 to 1981:
Member - State of Wisconsin High Blood Pressure Advisory Council - Wisconsin Affiliate
1979 to 1981:
Vice President - Endstage Renal Disease Program, HEW - Network Coordinating Council (formerly Network 13)
1979 to 1981:
Alternate Member - Medical Review Board - Network Coordinating Council (formerly network 13)
1980 to 1981:
Vice-Chairman - State of Wisconsin High Blood Pressure Advisory Council - Wisconsin Affiliate
1980 to 1982:
President - Advisory Council - National Kidney Foundation of Wisconsin
1981 to 1982:
Chair - Medical and Scientific Committee - National Kidney Foundation of Wisconsin
1981 to 1982:
President - Executive Committee - North Central Chapter - National Kidney Foundation of Wisconsin
1981 to 1982:
Delegate - National Medical Advisory Board - National Kidney Foundation of the United States
1976 to 1983:
Executive Committee - Endstage Renal Disease Program, HEW - Network Coordinating Council (formerly Network 13)
1976 to 1983:
Representative for Marshfield Clinic - Endstage Renal Disease Program, HEW - Network Coordinating Council (formerly Network 13)
1979 to 1983:
Member - Subcommittee on Blood Utilization - Marshfield Clinic, Marshfield, Wisconsin
1979 to 1983:
Chair - Hypertension Risk Factor Committee - American Heart Associate Wisconsin Affiliate
1979 to 1983:
Member - Program Council - American Heart Associate Wisconsin Affiliate
1974 to 1984:
Medical and Scientific Committee - National Kidney Foundation of Wisconsin
1975 to 1984:
Member - Board of Directors - North Central Chapter - National Kidney Foundation of Wisconsin Affiliate
1980 to 1984:
Member - Executive Committee - North Central Chapter - National Kidney Foundation of Wisconsin Affiliate
1980 to 1984:
Chair - Hypertension Risk Factor Educatiion Committee - American Heart Association
1983 to 1984:
Member - Critical Care Committee - Marshfield Clinic, Marshfield, Wisconsin
1979 to 1985:
Member - Board of Governors - American Heart Associate Wisconsin Affiliate
1983 to 1985:
Member - Computer Committee - Marshfield Clinic - Marshfield, Wisconsin
1984 to 1985:
Member - Business Committee - Marshfield Clinic - Marshfield, Wisconsin
1984 to 1985:
Member - Nominating Committee - American College of Physicians Wisconsin Chapter
1984 to 1986:
Member - Health and Public Policy - American College of Physicians Wisconsin Chapter
1973 to 1988:
Member - American College of Physicians
1973 to 1988:
Member - American Medical Association
1988 to 1988:
Member - American College of Chest Physicians
1988 to 1988:
Fellow - American College of Physicians
1985 to 1990:
Exam Exercises - Proctor - Clinical Medical - Marshfield Clinic - Marshfield, Wisconsin
1988 to 1990:
Member - Critical Care Committee - Marshfield Clinic - Marshfield, Wisconsin
1989 to 1990:
Secretary/Treasurer - Wisconsin Society of Internal Medicine Wisconsin Affiliate
1989 to 1990:
Member - Socioeconomic Program - Wisconsin Society of Internal Medicine Wisconsin Affiliate
1974 to 1991:
Member - American Society of Artifical Internal Organs
1985 to 1991:
Member - Associate Evaluation Committee - Marshfield Clinic, Marshfield, Wisconsin
1989 to 1991:
Chairman - Socioeconomic Program - Wisconsin Society of Internal Medicine Wisconsin Affiliate
1990 to 1991:
President Elect - Wisconsin Society of Internal Medicine Wisconsin Affiliate
1991 to 1991:
President - Wisconsin Society of Internal Medicine Wisconsin Affiliate
1987 to 1992:
Governing Council - Wisconsin Society of Internal Medicine Wisconsin Affiliate
1991 to 1993:
Member - Professional Practice Committee - Marshfield Clinic, Marshfield, Wisconsin
1991 to 1993:
Member - Section on Hypertension Steering Committee - American College of Chest Physicians
1992 to 1993:
Delegete - Leadership Conference - American Society of Internal Medicine
1991 to 1994:
Secretary - Medical Staff Executive Committee - St. Joseph's Hospital
1984 to 1995:
Member - Hypertension Risk Factor Education Committee - American Heart Association Wisconsin Affiliate
1987 to 1995:
Member - Research Committee - Marshfield Clinic Research Foundation
1994 to 1995:
Chair Steering Committee - Network Hypertension and Clinical Cardiology - American College of Chest Physicians
1985 to 1996:
Member-at-large - Board of Governors - American Heart Associate Wisconsin Affiliate
1994 to 1996:
Member - Health and Public Policy - American College of Physicians Wisconsin Chapter
1994 to 1996:
Co-Chair - Membership Committee - Wisconsin Society of Internal Medicine Wisconsin Affiliate
1995 to 1996:
Member - Research Awards Committee - Marshfield Clinic Research Foundation
1995 to 1996:
Chair - Managed Care Committee - American College of Physicians Wisconsin Chapter
1996 to 1996:
Co-Chair - Socioeconomic Program - Wisconsin Society of Internal Medicine Wisconsin Affiliate
1988 to 1997:
Marshfield Clinic/St. Joseph's Hospital Delegate - Upper Midwest Renal Network (13)
1994 to 1997:
Secretary - Treasurer - Wood County Medical Society
1994 to 1997:
Secretary-Treasurer - Executive Committee - Wood County Medical Society
1974 to 1998:
Member - Internal Medicine Residency Committee - Marshfield Clinic, Marshfield, Wisconsin
1974 to 1998:
Member - Clinical Evaluation Committee Residency Program - Marshfield Clinic Internal Medicine
1979 to 1998:
Member - Resident Applicant Selection Committee - Marshfield Clinic, Marshfield, Wisconsin
1984 to 1998:
Member - Combined Medical Education Committee - Marshfield Clinic, Marshfield, Wisconsin
1988 to 1998:
Member - International Society for Hypertension in Pregnancy
1997 to 1998:
Vice President - Wood County Medical Society
1997 to 1998:
Vice President - Executive Committee - Wood County Medical Society
1998 to 1998:
Member- Associate Evaluation Restructuring Committee - Marshfield Clinic, Marshfield, Wisconsin
1998 to 1998:
Member - Ad Hoc Personnel Committee on Tenure Policy - Marshfield Clinic Research Foundation, Marshfield, Wisconsin
1996 to 1999:
Co-Chair - Socioeconomic Program Annual Meeting, ACP/WSIM - American College of Physicians Wisconsin Chapter
1999 to 1999:
Member - Reference Committee on Socioeconomic Affairs - Wisconsin Medical Society (WMS)
1999 to 1999:
Certified Trainer - EPEC Project, EPEC Inc, Linda emanuel MD PhD, Principal - AMA Education for Physicians on End-of-Life-Care (EPEC)
1999 to 1999:
Fellow - American Heart Association
1974 to 2000:
Member - Advisory Council - National Kidney Foundation of Wisconsin
1995 to 2000:
Member - Health and Science Policy Committee - American College of Chest Physicians
1997 to 2000:
Chair - Membership Committee - Scientific Program, Annual Meeting ACP/WSIM
2000 to 2000:
Chair - Reference Committee on Socioeconomic Affairs - Wisconsin Medical Society (WMS)
2000 to 2000:
Member - Ad Hoc Planning Committee - AMA Education for Physicians on End-of-Life-Care (EPEC)
1993 to 2001:
Member - WMS Commission on Medicine and Ethics/Council on Ethcis and Judicial Activities (CEJA)
1998 to 2001:
President - Wood County Medical Society
1998 to 2001:
President - Executive Committee - Wood County Medical Society
1999 to 2001:
Member - Education Planning Committee - American Society of Nephrology/Renal Physicians Association
1999 to 2001:
Co-Chair - Subcommittee on Education - American Society of Nephrology/Renal Physicians Association
2000 to 2001:
Chair - WMS Commission on Medicine and Ethics/Council on Ethics and Judicial Activities (CEJA)
2001 to 2001:
Fellow - American Heart Association - Council for High Blood Pressure Research
2001 to 2001:
Chair - Reference Committee on State and National Affairs - Wisconsin Medical Society (WMS)
1975 to 2002:
Member - Program Committee - American College of Physicians Wisconsin Chapter
2000 to 2002:
Co-Chair - Scientific Program, Annual Meeting, ACP/WSIM
1999 to 2003:
Member - Board of Trustees Executive Committee - Marshfield Clinic Research Foundation
2001 to 2003:
Vice Chair - Board of Trustees - Marshfield Clinic Research Foundation
1974 to 2004:
Member - Censor and Review Committee - Wood County Medical Society
1988 to 2004:
Representative - Wood County Division Council - American Heart Associate Wisconsin Affiliate
1998 to 2004:
Institutional Review Board - Marshfield Clinic Research Foundation, Marshfield, Wisconsin
2001 to 2004:
Chair - Sub Committee Task Force on Professionalism - WMS Commission on Medicine and Ethics/Council on Ethics and Judicial Activities (CEJA)
2003 to 2004:
Chair - Board of Trustees - Marshfield Clinic Research Foundation
2004 to 2004:
Chair - Reference Committee on State and National Affairs - Wisconsin Medical Society (WMS)
1994 to 2005:
Executive Committee - Wood County Medical Society
2000 to 2005:
Member - Director's Internal Advisory Council - Marshfield Clinic Research Foundation
2003 to 2005:
Chair - Board of Trustees Executive Committee - Marshfield Clinic Research Foundation
2005 to 2005:
Fellow - American Society of Nephrology
2005 to 2005:
Chair - Reference Committee on State and National Affairs - Wisconsin Medical Society (WMS)
2005 to 2005:
Member - Reference Committee on Organization and Finance - Wisconsin Medical Society (WMS)
2004 to 2006:
Chair - Institutional Review Board - Marshfield Clinic Research Foundation, Marshfield, Wisconsin
2006 to 2006:
Member - Reference Committee on Organization and Finance - Wisconsin Medical Society (WMS)
1973 to 2007:
Member - Nephrology Rotation Teaching Staff - Marshfield Clinic, Marshfield, Wisconsin
1981 to 2007:
Editorial Committee Member - Marshfield Clinic Bulletin/Clinical Medicine and Research
1991 to 2007:
Chairman - Associate Evaluation Committee - Marshfield Clinic, Marshfield, Wisconsin
1995 to 2007:
Editor-in-Chief - Marshfield Clinic Bulletin/Clinical Medicine and Research
1998 to 2007:
Medical and Scientific Committee - National Kidney Foundation of Wisconsin
2006 to 2007:
Member - CORAL Committee on Risk Factor Management
2006 to 2007:
Member - Cardiovascular Measurement Advisory Panel - National Committee for Quality Assurance (NCQA)
2006 to 2008:
Invited member for WMS Board of Directors - Health of the Population - State of Wisconsin Steering Committee - WMS and UW School of Population Health Institute
2007 to 2008:
Chair - Awards Committee - Scientific Program, Annual Meeting ACP/WSIM
2007 to 2008:
Vice Chair Strategic Policy Panel WMS BOD - Wisconsin Medical Society (WMS)
2007 to 2009:
Co-Chair and Board Member - Independent Coumadin Data and Safety Monitoring Board (DSMB) for the Modeling Genotyping Study
2007 to 2009:
Invited Representative, Member of WMS Board of Directors - Wisconsin Literacy Organization
2009 to 2009:
Attendee - Health of the Population Conference - WMS and UW School of Population Health Institute
2009 to 2009:
Invited Attendee for WMS Board of Directors - National Symposium, on Medical and Health Care Education Reform, Mayo Clinic, Rochester, Minnesota (April 2009)
1999 to 2010:
Member - Faculty for Education for Physicians on End-of-Life Care - American College of Chest Physicians
2007 to 2010:
Member Ad Hoc High Blood Pressure Workgroup - State of Wisconsin Department of Health Services (DHS) Heart Disease and Stroke Alliance/formerly Department of Health and Family Services (DHFS)
2007 to 2010:
Member from District 4 - Board of Directors - Wisconsin Medical Society (WMS)
2010 to 2010:
ASH Task Force by Appointment of ASM President, George Bakeris, MD, "ASH BP Initiative" Brent Egan, Chair MD
2010 to 2012:
Member - AHA Council High Blood Pressure Res. Professional Education of Pub Committee
1999 to 2014:
Delegate - House of Delegates - Wisconsin Medical Society (WMS)
2006 to 2014:
Member Board of Directors - Wisconsin Medical Society
1989 to 2015:
Fellow - American College of Chest Physicians
1973 to Present:
Member - American Society of Nephrology
1973 to Present:
Member - Wisconsin Medical Society
1974 to Present:
Member - International Society of Nephrology
1974 to Present:
Member - Wood County Medical Society
1977 to Present:
Member - Wisconsin Affiliate - American Heart Association
1978 to Present:
Governor's Council - Scientific Program, Annual Meeting ACP/WSIM
1987 to Present:
Member - Council for High Blood Pressure Research
1987 to Present:
Member - Council for Kidney and Heart Disease
1991 to Present:
Member - Network Hypertension and Clinical Cardiology - American College of Chest Physicians
1992 to Present:
Member - American Medical Association
1995 to Present:
Chair - Advisory Council - Chronic Disease Program (CDP) - State of Wisconsin Department of Health Services (DHS) Heart Disease and Stroke Alliance/formerly Department of Health and Family Services (DHFS)
1995 to Present:
Consultant - Network Hypertension and Clinical Cardiology - American College of Chest Physicians
2001 to Present:
WMS Council on Legislative Activities
2002 to Present:
Member - Ethics Committee Network - American College of Chest Physicians
2002 to Present:
Member - End-of-Life Care Network - American College of Chest Physicians
2007 to Present:
Member - Health Care Quality and Access - Scientific Program, Annual Meeting ACP/WSIM
2007 to Present:
Consultant on High Blood Pressure - State of Wisconsin Department of Health Services (DHS) Heart Disease and Stroke Alliance/formerly Department of Health and Family Services (DHFS)
2007 to Present:
Member - Strategic Policy Panel WMS BOD - Wisconsin Medical Society (WMS)
2008 to Present:
Member - Sphygomanometer Sub Committee - Association for the Advancement of Medical Instrumentation (AAMI)
2010 to Present:
Chair - Vice Chair Strategic Policy Panel WMS BOD - Wisconsin Medical Society (WMS)
2011 to Present:
Director-at-Large - Wisconsin Medical Society
2015 to Present:
Master - American College of Physicians

Committees


1976 to 1978:
Membranous Glomerulonephritis, Collaborative Study in the CM Coggins Marshfield Site, Principal Investigator
1981 to 1982:
High Molecular Weight Angiotensinogen Levels in Hypertensive Pregnant Women - Marshfield Clinic Research Foundation, Co-Investigator
1981 to 1985:
First Presbyterian Church of Marshfield, Wisconsin, Elder
1987 to 1989:
Nominating Committee - First Presbyterian Church, Marshfield, Wisconsin, Member
1988 to 1989:
Nominating Committee - First Presbyterian Church, Marshfield, Wisconsin, Chairman
1994 to 1994:
Retrospective analysis of results of ambulatory blood pressure monitoring: Marshfield Clinic experience, Principal Investigator
1993 to 1995:
Trial of enalapril versus diltiazem in idiopathic membranous nephropathy with nephrotic syndrome in adults - Marshfield, Principal Investigator
1994 to 1996:
Personnel Committee - First Presbyterian Church, Marshfield, Wisconsin, Recording Secretary
1996 to 1996:
Personnel Committee - First Presbyterian Church, Marshfield, Wisconsin, Acting Chairman
1994 to 1998:
The Glomerular Disease Collaborative Network's Treatment (GDCN) protocol for relapsing glomerulonephritis and vasculitis associated with anti-neutrophil cytoplasmic autoantibodies (ANCA). Glomerular Disease Collaborative Network (GDCN), Co-Investigator
1989 to 1999:
Personnel Committee - First Presbyterian Church, Marshfield, Wisconsin, Member
1996 to 1999:
Irbesartan in Hypertensive Type II Diabetic Subjects with Proteinuria, Principal Investigator
1997 to 1999:
A study of angiotensinogen and acute phase response, Co-Investigator
1995 to 2000:
Adult IgA Nephropathy, Principal Investigator
1999 to 2000:
IgA Nephropathy in Young Adults, Principal Investigator
2000 to 2002:
Omapatrilat Cardiovascular Treatment Assessment Versus Enalapril (Octave), Co-Investigator
2000 to 2002:
A study evaluating the initiation and titration of fixed doses of novel erythropoiesis stimulating protein (NESP) therapy in subjects with chronic renal insufficiency (CRI), Co-Investigator
2000 to 2002:
Pilot study of mycophenolate mofetil in children with steroid-dependent nephrotic syndrome SPN3, Principal Investigator
2000 to 2002:
A double-blind, randomized dose-response study of Losartan in children with hypertension, Co-Investigator
2001 to 2002:
A Phase II, multicenter, double-blinded, placebo-controlled, clinical study to determine the effect of DTI-0026 on the treatment of glomerulonephritis, Principal Investigator
2002 to 2002:
Prevalence and Characteristics of Sleep Apnea in the Marshfield Epidemiologic Study Area (MESA), Principal Investigator
1994 to 2003:
ALLHAT STUDY (Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial), NHLBI, University of Texas, Houston Health Science Center, Principal Investigator
2003 to 2003:
Piloting Retrospective Application of a Newly Developed Assessment Tool for Outcomes Following Renovascular Interventions, Marshfield Clinic Experience, Principal Investigator
2001 to 2004:
Retrospective analysis of Hypertensive Arteriolo-nephrosclerosis by renal histology to Serum Uric Acid and estimated Glomerular Filtration Rate (GFR), a clinical correlation. Marshfield Clinic Experience, Principal Investigator
1998 to 2006:
Genetic markers for focal segmental glomerulonephritis, Principal Investigator
2004 to 2006:
Identification of TGF beta Antagonists, Co-Investigator
2002 to 2007:
A Randomized Controlled Trial of Mycophenolate Mofetil in Patients with IgA Neuropathy: MMF Study, Principal Investigator
2003 to 2007:
Secondary Prevention of Small Subcortical Strokes, Co-Investigator
2004 to 2007:
A Prospective, Multinational, Multicenter, Double-Blind. Randomized, Active-Controlled Trial to Compare the effects of various study drugs Combined on the Reduction of Cardiovascular Morbidity and mortality in Patients with High Risk Hypertension, Principal Investigator
2004 to 2007:
A multi-center, prospective, randomized trial to compare the effectiveness of a treatment regimen including CSA to a regimen including MMF and oral pulse steroids in inducing remission of proteinuria in patients with steroid resistant Focal Segmental, Principal Investigator
2005 to 2007:
Cardiovascular Outcomes in Renal Atherosclerotic Lesions, Co-Investigator
2005 to 2007:
Study of Heart and Renal Protection, Principal Investigator
2005 to 2007:
The Effect of Study Drug in Overt Type 2 Diabetic Nephropath, Principal Investigator
2005 to 2007:
The Collaborative Study Trial: The Effect of Study Drug in Patients with Type 2 Diabetes and Miroalbuminuria, Principal Investigator
2005 to 2007:
The Clinical Role of B-Type Natriuretic Peptide in Patients with Chronic Kidney Disease, Co-Investigator
2007 to 2008:
Steering Committee House of the Dove - St. Joseph's Hospital, Member
2004 to 2009:
A Prospective, Multinational, Multicenter, Double-Blind. Randomized, Active-Controlled Trial to Compare the effects of Lotrel (Amiodipine/Benazepril) to Benazepril and Hydrochlorothiazide Combined on the Reduction of Cardiovascular Morbidity & Mortality, Principal Investigator
2010 to 2010:
ASH Task Force - ASH Blood Pressure Initiative, Member
2010 to 2010:
WMS Nominating Committee, Member
2010 to 2010:
WMS Strategic Planning Committee, Member
2010 to 2012:
AHA Council on High Blood Pressure Research Public and Professional Education Committee, Member
2010 to 2012:
ACP Wisconsin - Resolution Committee, Chair
2010 to 2013:
Institutional Review Board - Marshfield Clinic Research Foundation, Member

Select Publications


  • Shimpi N., Dart R., Umukoro P., Acharya A.. . Interdisciplinary Care Model: Cardiovascular Diseases and Oral Health. In: Integration of Medical and Dental Care and Patient Data.. 2nd ed.Switzerland: Springer Publishing Company; 2019: pp. 71-85.
  • Teixeira PL, Wei WQ, Cronin RM, Mo H, VanHouten JP, Carroll RJ,...Denny JC [including LaRose E, Dart RA, Nikolai AM, Peissig PL.] (2017 January). Evaluating electronic health record data sources and algorithmic approaches to identify hypertensive individuals. J Am Med Inform Assoc.
    PubMed ID: 27497800
  • Epperla N, Ye F, Idris A, Sakkalaek A, Liang H, Chyou PH,...Yale S [including Dart RA, Mazza J.] (2017 May 19). Treatment-Related Cardiovascular Outcomes in Patients with Symptomatic Subclavian Artery Stenosis. Cureus. 9(5):e1262.
    PubMed ID: 28652946
  • Elijovich F, Weinberger MH, Anderson CA, Appel LJ, Bursztyn M, Cook NR,...Laffer CL [including Dart RA.] (2016 Sep). Salt Sensitivity of Blood Pressure: A Scientific Statement From the American Heart Association. Hypertension. 68(3):e7-e46.
    PubMed ID: 27443572
  • Dart RA, Haws RM.. (2015 February). The Clinician and Clinical Research: Barriers and Opportunities. Clinical Researcher. 2(1):32-35.
  • Bielinski SJ, Pathak J, Carrell DS, Takahashi PY, Olson JE, Larson NB,...Roger VL [including Dart RA, Peissig P, Linneman JG.] (2015 August 21). A Robust e-Epidemiology Tool in Phenotyping Heart Failure with Differentiation for Preserved and Reduced Ejection Fraction: the Electronic Medical Records and Genomics (eMERGE) Network. J Cardiovasc Transl Res. 8 :475-83.
    PubMed ID: 26195183
  • Alpert BS, Dart RA, SICA DA. (2015). Public Use Blood Pressure Kiosks: A Guide for Clinicians. http://www.ash-us.org/documents/files/2015/150422-DOCUMENT-Guide-Public-Use-BP-Kiosks-(3).pdf.
  • Dart RA, Egan BM. (2014 June). Formation of Community-Based Hypertension Practice Networks: Success, Obstacles, and Lessons Learned J Clin Hypertens (Greenwich). 16(6):393-7.
    PubMed ID: 24666425
  • Dart RA, Alpert B, Quinn D. (2014 April). Effect of mechanical behavior of the brachial artery on blood pressure measurement during cuff inflation and cuff deflation Blood Press Monit. 19(2):120.
    PubMed ID: 24618886
  • Carbone RG, Algahim MF, Rizzo S, Monselise A, Dart RA, Almassi GH, Gutterman DD. (2014 May). Cardiovascular risk in patients without known cardiovascular disease. Eur Rev Med Pharmacol Sci. 18(3):365-73.
    PubMed ID: 24563436
  • Dart RA, Onitilo AA, Salzman SA, Reed KD, Shukla SK. (2014 September). Ten years of Clinical Medicine & Research. Clin Med Res. 12(1-2):1.
  • Alpert BS, Dart RA, Sica DA. (2014 August). Public-use blood pressure measurement: the kiosk quandary. J Am Soc Hypertens.. 8(10):739-42.
    PubMed ID: 25418496
  • Reisin E, Graves JW, Yamal JM, Barzilay JI, Pressel SL, Einhorn PT,...for the ALLHAT Collaborative Research Group [including Dart RA.] (2014 July). Blood pressure control and cardiovascular outcomes in normal-weight, overweight, and obese hypertensive patients treated with three different antihypertensives in ALLHAT. JOURNAL OF HYPERTENSION. 32(7):1503-13.
    PubMed ID: 24842697
  • Elkind M, Luna J, McClure L, Karanjia PN, Murali NS, Dart RA, Mancl KK. (2014 March). C-reactive protein as a prognostic marker after lacunar stroke: levels of inflammatory markers in the treatment of stroke study. STROKE. 45(3):707-16.
    PubMed ID: 24523037
  • Alpert BS, Dart RA, Quinn D. (2014 October 19). Oscillometric blood pressure: calculated risk or reward. Blood Press Monit. 19(5):255.
    PubMed ID: 25198793
  • Piller LB, Simpson LM, Baraniuk S, Habib GB, Rahman M, Basile JN,...Davis BR [including Dart RA.] (2014 November). Characteristics and long-term follow-up of participants with peripheral arterial disease during ALLHAT. J Gen Intern Med. 29(11):1475-83.
    PubMed ID: 25002161
  • Dart RA. (2013 October). Re: Zheng, Pan and Murray “Effect of mechanical behavior of the brachial artery on blood pressure measurement during cuff inflation and cuff deflation.” Blood Press Monit. 18(5):265-71.
  • McCarty CA, Berg RL, Rottscheit CM, Dart RA. (2013 November). The use of dietary supplements and their association with blood pressure in a large Midwestern cohort. BMC Complement Altern Med. 13 :339.
    PubMed ID: 24283381
  • Margolis KL, Davis BR, Baimbridge C, Ciocon JO, Cuyjet AB, Dart RA,...ALLHAT Collaborative Research Group. (2013 August). Long-term follow-up of moderately hypercholesterolemic hypertensive patients following randomization to pravastatin vs usual care: the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT-LLT). J Clin Hypertens (Greenwich). 15(8):542-54.
    PubMed ID: 23889716
  • Margolis KL, Davis BR, Baimbridge C, Ciocon JO, Cuyjet AB, Dart RA,...Williamson JD. (2013 December). Author response to lipid-lowering in African Americans in ALLHAT-optimism bias? J Clin Hypertens (Greenwich). 15(12):941.
    PubMed ID: 24299695
  • Pan N, Frome WL, Dart RA, Tewksbury DA, Luo J. (2013 February). Expression of the renin-angiotensin system in a human placental cell line. Clinical Medicine & Research. 11(1):1-6.
    PubMed ID: 22997355
  • Drawz PE, Baraniuk S, Davis BR, Brown CD, Colon PJ, Cuyjet AB,...Rahman M [including Dart RA.] (2012 December). Cardiovascular risk assessment: Addition of CKD and race to the Framingham equation AMERICAN HEART JOURNAL. 164(6):925-931.e2.
    PubMed ID: 23194494
  • Okon TR, Vats HS, Dart RA. (2011 July). Palliative medicine referral in patients undergoing continuous renal replacement therapy for acute kidney injury. Ren Fail. 33(7):707-17.
    PubMed ID: 21787162
  • Vats HS, Dart RA, Okon TR, Liang H, Paganini EP. (2011 July). Does early initiation of continuous renal replacement therapy affect outcome: experience in a tertiary care center. Ren Fail. 33(7):698-706.
    PubMed ID: 21787161
  • Piller LB, Baranjuk S, Simpson LM, Cushman WC, Massie BM, Einhorn PT,...ALLHAT Collaborative Research Group [including Dart RA.] (2011 October). Long-term follow-up of participants with heart failure in the antihypertensive and lipid-lowering treatment to prevent heart attack trial (ALLHAT). CIRCULATION. 124(17):1811-8.
    PubMed ID: 21969009
  • Kopp JB, Nelson GW, Sampath K, Johnson RC, Genovese G, An P,...Winkler CA [including Dart RA.] (2011 November). APOL1 genetic variants in focal segmental glomerulosclerosis and HIV-associated nephropathy. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY. 22(11):2129-37.
    PubMed ID: 21997394
  • Wiley CL, Switzer SP, Berg RL, Glurich IE, Dart RA. (2010 March). Association of B-type natriuretic peptide (BNP) levels with estimated glomerular filtration rate (eGFR) and congestive heart failure (CHF). Clinical Medicine & Research. 8(1):7-11.
    PubMed ID: 19920165
  • Grimm R, Davis B, Piller L, Cutler J, Margolis K, Barzilay J,...ALLHAT Collaborative Research Group [including Dart RA.] (2009 September). Heart Failure in ALLHAT: Did blood pressure medication at study entrance influence outcome? J Clin Hypertens (Greenwich). 11(9):466-74.
    PubMed ID: 19751458
  • Dart RA. (2009). Professionalism: A 'critical care' component in health care reform. WMJ. 108(9):435-6.
  • Wilke RA, Simpson RU, Mukesh BNanjan, Bhupathi S, Dart RA, Ghebranious N, McCarty CA. (2009 November). Genetic variation in CYP27B1 is associated with congestive heart failure in patients with hypertension. PHARMACOGENOMICS. 10(11):1789-97.
    PubMed ID: 19891555
  • Chiong JR, Aronow WS, Khan IA, Nair CK, Vijayaraghavan K, Dart RA,...Geraci SA. (2008 February). Secondary hypertension: current diagnosis and treatment. Int J Cardiol. 124(1):6-21.
    PubMed ID: 17462751
  • Wright JT, Harris-Haywood S, Pressel S, Barzilay J, Baimbridge C, Bareis CJ,...Davis BR [including Dart RA.] (2008 January). Clinical outcomes by race in hypertensive patients with and without the metabolic syndrome. ARCHIVES OF INTERNAL MEDICINE. 168(2):207-217.
    PubMed ID: 18227370
  • Black HR, Dave BJ, Barzilay J, Nwachuku CE, Baimbridge C, Marginean H,...Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial [including Dart RA.] (2008 February). Metabolic and clinical outcomes in nondiabetic individuals with the metabolic syndrome assigned to chlorthalidone, amlodipine, or lisinopril as initial treatment for hypertension: a report from the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). DIABETES CARE. 31(2):353-60.
    PubMed ID: 18000186
  • Kopp JB, Smith JW, Nelson GW, Johnson RC, Freedman BI, Bowden DW,...Winkler CA [including Dart RA.] (2008 October). MYH9 is a major-effect risk gene for focal segmental glomerulosclerosis. NATURE GENETICS. 40(10):1175-84.
    PubMed ID: 18794856
  • McKenzie LM, Hendrickson SL, Briggs WA, Dart RA, Korbet SM, Mokryzcki M,...Winkler CA. (2007 November). NPHS2 variation in sporadic focal segmental glomerulosclerosis. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY. 18(11):2987-95.
    PubMed ID: 17942957
  • Dart RA, Salzman SA. (2006 September). Expression of concern - Sudbo J. Novel management of oral cancer: a paradigm of predictive oncology. Clin Med Res 2004;2:233-242. Clin Med Res. 4(3):160.
    PubMed ID: 16988092
  • Leenen FH H, Nwachuku CE, Black HR, Cushman WC, Davis BR, Simpson LM,...ALLHAT Collaborative Research Group [including Dart RA.] (2006 July). Clinical events in high-risk hypertensive patients randomly assigned to calcium channel blocker versus angiotensin-converting enzyme inhibitor in the antihypertensive and lipid-lowering treatment to prevent heart attack trial. Hypertension. 48(3):374-384.
    PubMed ID: 16864749
  • Pan N, Luo J, Kaiser SJ, Frome WL, Dart RA, Tewksbury DA. (2006 November). Specific receptor for angiotensinogen on human renal cells. Clin Chim Acta. 373(1-2):32-36.
    PubMed ID: 16764846
  • Burmester JK, Salzman SA, Zhang KQi, Dart RA. (2006 November). Small molecule antagonists of the TGF-beta1/TGF-beta receptor binding interaction. Med Oncol. 23(4):553-562.
    PubMed ID: 17303915
  • Orloff MS, Iyengar SK, Winkler CA, Goddard KAB, Dart RA, Ahuja TS,...Kopp JB. (2005 April). Variants in the Wilms' tumor gene are associated with focal segmental glomerulosclerosis in the African American population. Physiol Genomics. 21(2): 212-221.
    PubMed ID: 15687485
  • Dart RA. (2005 August). The clinical utility of patient-measured blood pressure at home in the management of hypertension. Clin Med Res. 3(3):134-136.
    PubMed ID: 16160067
  • Emanuel L, Alexander C, Arnold RM, Bernstein R, Dart RA, Dellasantina C,...the Palliative Care Guidelines Group of the American Hospice Foundation. (2004 December). Integrating palliative care into disease management guidelines. J Palliative Med. 7(6):774-783.
    PubMed ID: 15684844
  • Moss AH, Holley JL, Davison SN, Dart RA, Germain MJ, Cohen L, Swartz RD. (2004 January). Core curriculum in nephrology. Palliative care. Am J Kidney Dis. 43(1):172-173.
    PubMed ID: 14712442
  • Dart RA, Vidaillet HJ. (2003). Medical complications of obstructive sleep apnea. In: Braunwald E, Fauci AS, Isselbacis KJ, Kasper L, Hauser SL, Longo DL, Jameson JL (Ed.), Harrison's Online (Harrison's Principles of Internal Medicine) McGraw Hill.
  • Dart RA, Gollub S, Lazar J, Nair C, Schroeder D, Woolf SH. (2003 January). Treatment of systemic hypertension in patients with pulmonary disease. COPD and asthma. Chest. 123(1):222-243.
    PubMed ID: 12527626
  • Dart RA, Gregoire JR, Gutterman DD, Woolf SH. (2003 January). The association of hypertension and secondary cardiovascular disease with sleep-disordered breathing. Chest. 123(1):244-260.
    PubMed ID: 12527627
  • Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL,...Vidaillet HJ [including Dart RA.] (2003 December). Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension. 42(6):1206-1252.
    PubMed ID: 14656957
  • Dart RA. (2003 January). Editorial welcome. Clin Med Res. 1(1):1.
  • Dart RA, Wisconsin Medical Society's Task Force on Professionalism. (2003 January). Task force releases report. Part I: Professionalism defined. WMJ. 102(1):7-8.
    PubMed ID: 12679963
  • Dart RA, Jensen NM. (2003 May). Citizen congress takes shape. WMJ. 102(5):7-8.
    PubMed ID: 14621923
  • Dart RA. (2003). Obesity, obstructive sleep apnea and heart failure. Letter, New Engl J Med
  • Dart RA. (2002 December). Obesity and the risk of heart failure. N Engl J Med. 347(23):1888.
    PubMed ID: 12472069
  • Lichter-Konecki UP, Broman KW, Dart RA, Blau EB, Konecki DS. (1999). Mapping of the Locus for Autosomal Dominant Renal Fanconi Syndrome. Am J Hum Genet. 65 :A100.
  • Donadio JV, Grande JP, Bergstralh EJ, Dart RA, Larson TS, Spencer DC. (1999 August). The long-term outcome of patients with IgA nephropathy treated with fish oil in a controlled trial. Mayo Nephrology Collaborative Group. J Am Soc Nephrol. 10(8):1772-1777.
    PubMed ID: 10446945
  • Dart RA. (1999 May). The postoperative period summary. Chest. 115(5 Suppl):48S-49S.
    PubMed ID: 10331332
  • Eaker ED, Dart RA, Wittman LM. (1998 April). Correlates of blood pressure control in a population-based sample of rural women. American Journal of Hypertension. 11:4, Part 2
  • Sheps SG, Dart RA. (1998 February). New guidelines for prevention, detection, evaluation, and treatment of hypertension: Joint National Committee VI. Chest. 113(2):263-265.
    PubMed ID: 9498933
  • Dart RA, Berg RL. (1996 December). The clinical utility of ambulatory blood pressure monitoring in a multispecialty clinic setting. Blood Press Monit. 1(6):475-480.
    PubMed ID: 10226278
  • Dart RA. (1995 February). Cost as a factor in the treatment of hypertension. Contemp Intern Med. 7(2):10-14.
    PubMed ID: 10150334
  • Dart RA. (1989). The hypertensive patient workshop: introduction to aspects of hypertension. Marshfield Clinic Bulletin.
  • Tewksbury DA, Burrill RE, Tyron ES, Dart RA. (1988). Study on high molecular weight angiotensinogen. Proceedings of the International Congress on Placental and Endometrial Proteins Meeting. :651-654.
  • Parker JP, Dart RA, Duffy DP. (1987). Tubulo-Interstitial Nephropathy and Urinary Tract Infections. Current Clinical Practice, WB Saunders Co., Philadelphia (F.H. Messerli, ed.). :507-512.
  • Tewksbury DA, Tyron ES, Burrill RE, Dart RA. (1986 July). High molecular weight angiotensinogen: a pregnancy associated protein. Clin Chim Acta. 158(1):7-12.
    PubMed ID: 3742816
  • Duffy DP, Mulligan GM, Dart RA. (1986). An ultrasonic approach to secondary hyperparathyroidism: advances in continuous ambulatory peritoneal dialysis. Peritoneal Dialysis Bulletin. :81-83.
  • Gray R, Marx JJ, Dart RA. (1985). Raji cell assay for immune complexes by immunofluorescence. J Med Tech. 2 :55-59.
  • Dart RA. (1985). The kidneys and diabetes. Marshfield Clinic Bulletin. 6 :181-195.
  • Dart RA. (1985). Kidneys, diabetes, and end stage renal disease. Marshfield Clinic Bulletin. 7 :217-230.
  • Friedenberg WR, Marx JJ, Dart RA, Parker JP, Winemiller RH. (1983). Granulocyte function using nandrolone decanoate in patients on matinenance hemodialysis. Dialysis and Transplantation. 12 :838-846.
  • Tewksbury DA, Dart RA. (1982 September). High molecular weight angiotensinogen levels in hypertensive pregnant women. Hypertension. 4(5):729-734.
    PubMed ID: 7106939
  • Tewksbury DA, Dart RA. (1981). Molecular weight studied on high molecular weight human angiotensinogen. In: Sambhi, M P (Ed.), Heterogeneity of Renin and Renin substrate (pp. 261-270). New York: Elsevier North Holland, Inc..
  • Tewksbury DA, Dart RA, Travis J. (1981 April). The amino terminal amino acid sequence of human angiotensinogen. Biochem Biophys Res Commun. 99(4):1311-1315.
    PubMed ID: 7259779
  • Tewksbury DA, Dart RA. (1980). Quantitation of High Molecular Weight Human Angiotensinogen. Fed Proc. 39 :1864.
  • Tewksbury DA, Dart RA. (1980). Quantitation of High Molecular Weight Angiotensinogen Levels in Hypertensive Pregnant women. CIRCULATION. 62 :III-89.
  • Handy GA, Dart RA, Koehn A. (1979 November). Wisconsin high blood pressure control program--involving the physician. Wis Med J. 78(11):14-16.
    PubMed ID: 516783
  • Tewksbury DA, Dart RA. (1979 September). Human plasma angiotensinogen: a review of purification procedures. Mol Cell Biochem. 27(1):47-56.
    PubMed ID: 390363
  • Tewksbury DA, Dart RA. (1979). Studies on the Characterization of Human Angiotensinogen. CIRCULATION. 60 :II-132.
  • Winchester JF, Gelfand MD, Knepshield JH, Dart RA. (1977). Dialysis and hemoperfusion of poisons and drugs. ASAIO. XXIII :752-808.
  • Dustan HP, Tarazi RC, Bravo EL, Dart RA. (1973 May). Plasma and extracellular fluid volumes in hypertension. Circ Res. 32(Suppl 1):73-83.
    PubMed ID: 4712515